+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Tendon Allograft Market Size, Share & Trends Analysis Report By End User (Hospitals, Orthopedic Clinics, and Others), By Product Type (Patellar Tendon, Tibialis, Achilles Tendon, and Others), By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 93 Pages
  • July 2024
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5988580
The North America Tendon Allograft Market is projected to witness market growth of 4.4% CAGR during the forecast period (2024-2031).

The US market dominated the North America Tendon Allograft Market, by Country in 2023, and is forecast to continue being a dominant market till 2031; thereby, achieving a market value of $9.32 billion by 2031. The Canada market is exhibiting a CAGR of 6.6% during (2024 - 2031). Additionally, The Mexico market is projected to experience a CAGR of 5.7% during (2024 - 2031).



Tendon allografts are biological tissues derived from human donors, used to repair or reconstruct damaged patient tendons. Unlike autografts, which involve taking tissue from the patient’s body, or synthetic implants, tendon allografts are sourced from deceased or living donors who have consented to tissue donation. These allografts undergo rigorous screening, processing, and sterilization to ensure they are safe and effective for medical use.

The market has emerged as a vital segment within the broader orthopedic and medical devices industry, reflecting significant advancements in medical technology and surgical practices. This market is gaining momentum due to a combination of factors, including advancements in surgical techniques, increasing incidence of sports injuries, a growing aging population, and a rising preference for biologic solutions over synthetic options. In addition, the expansion of the market is made possible by the developing healthcare infrastructure in emerging markets as well as the growing knowledge of the benefits of tendon allografts among both members of the medical community and patients.

In Mexico, the rise in sports participation and related injuries boosts the demand for tendon allografts. The Mexican Ministry of Health reports that sports injuries are a leading cause of musculoskeletal issues in the country, with a significant number involving tendon damage. Soccer, the most popular sport in Mexico, accounts for a substantial portion of these injuries. The growing adoption of tendon allografts in orthopedic surgeries, supported by the increasing number of trained orthopedic surgeons and advancements in medical facilities, propels the demand for tendon allografts in Mexico. Therefore, the region will present lucrative growth opportunities for the regional market.

List of Key Companies Profiled

  • INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • Conmed Corporation
  • RTI Surgical, Inc.
  • Arthrex, Inc.
  • Organogenesis Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.
  • B.Braun Melsungen AG (Aesculap, Inc.)
  • Stryker Corporation
  • MIMEDX Group, Inc.

Market Report Segmentation

By End User
  • Hospitals
  • Orthopedic Clinics
  • Others
By Product Type
  • Patellar Tendon
  • Tibialis
  • Achilles Tendon
  • Others
By Country
  • US
  • Canada
  • Mexico
  • Rest of North America

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Tendon Allograft Market, by End User
1.4.2 North America Tendon Allograft Market, by Product Type
1.4.3 North America Tendon Allograft Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. North America Tendon Allograft Market, by End User
4.1 North America Hospitals Market, by Country
4.2 North America Orthopedic Clinics Market, by Country
4.3 North America Others Market, by Country
Chapter 5. North America Tendon Allograft Market, by Product Type
5.1 North America Patellar Tendon Market, by Country
5.2 North America Tibialis Market, by Country
5.3 North America Achilles Tendon Market, by Country
5.4 North America Others Market, by Country
Chapter 6. North America Tendon Allograft Market, by Country
6.1 US Tendon Allograft Market
6.1.1 US Tendon Allograft Market, by End User
6.1.2 US Tendon Allograft Market, by Product Type
6.2 Canada Tendon Allograft Market
6.2.1 Canada Tendon Allograft Market, by End User
6.2.2 Canada Tendon Allograft Market, by Product Type
6.3 Mexico Tendon Allograft Market
6.3.1 Mexico Tendon Allograft Market, by End User
6.3.2 Mexico Tendon Allograft Market, by Product Type
6.4 Rest of North America Tendon Allograft Market
6.4.1 Rest of North America Tendon Allograft Market, by End User
6.4.2 Rest of North America Tendon Allograft Market, by Product Type
Chapter 7. Company Profiles
7.1 Integra LifeSciences Holdings Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 SWOT Analysis
7.2 ConMed Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.6 SWOT Analysis
7.3 RTI Surgical, Inc.
7.3.1 Company Overview
7.4 Arthrex, Inc.
7.4.1 Company Overview
7.4.2 SWOT Analysis
7.5 Organogenesis Holdings, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Research & Development Expenses
7.6 Zimmer Biomet Holdings, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Acquisition and Mergers:
7.6.6 SWOT Analysis
7.7 B. Braun Melsungen AG (Aesculap, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 SWOT Analysis
7.8 Stryker Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 Recent strategies and developments:
7.8.5.1 Product Launches and Product Expansions:
7.8.5.2 Acquisition and Mergers:
7.8.6 SWOT Analysis
7.9 MiMedx Group. Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Research & Development Expenses
7.9.4 Recent strategies and developments:
7.9.4.1 Product Launches and Product Expansions:
7.9.5 SWOT Analysis

Companies Mentioned

  • INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • Conmed Corporation
  • RTI Surgical, Inc.
  • Arthrex, Inc.
  • Organogenesis Holdings, Inc.
  • Zimmer Biomet Holdings, Inc.
  • B. Braun Melsungen AG (Aesculap, Inc.)
  • Stryker Corporation
  • MIMEDX Group, Inc.

Methodology

Loading
LOADING...